MARKET

POLBF

POLBF

POOLBEG PHARMA PLC
OTCPK
0.151
NaN%
Closed 09:30 05/16 EDT
OPEN
--
PREV CLOSE
0.151
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.196
52 WEEK LOW
0.151
MARKET CAP
75.50M
P/E (TTM)
-13.7273
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at POLBF last week (0505-0509)?
Weekly Report · 5d ago
Weekly Report: what happened at POLBF last week (0428-0502)?
Weekly Report · 05/05 11:10
Weekly Report: what happened at POLBF last week (0421-0425)?
Weekly Report · 04/28 11:19
Weekly Report: what happened at POLBF last week (0414-0418)?
Weekly Report · 04/21 11:19
Weekly Report: what happened at POLBF last week (0407-0411)?
Weekly Report · 04/14 11:08
Weekly Report: what happened at POLBF last week (0331-0404)?
Weekly Report · 04/07 11:08
Weekly Report: what happened at POLBF last week (0324-0328)?
Weekly Report · 03/31 11:19
Weekly Report: what happened at POLBF last week (0317-0321)?
Weekly Report · 03/24 11:07
More
About POLBF
Poolbeg Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is engaged in the development of medicines to address the unmet need for infectious and other prevalent diseases. The Company is involved in the development of a range of pharmaceutical products. Its product pipeline includes POLB 001, POLB 001 Oncology, POLB 001 Influenza, AI Programs, Oral GLP-1R Agonist. Its POLB 001 aims to target the Cytokine Release Syndrome (CRS) associated with many cancer immunotherapy treatments which impacts 70% of patients undergoing CAR T or Bispecific Antibody therapy. The Company uses artificial intelligence to identify infectious disease drug targets & treatments. Its Oral GLP-1R Agonist is a delivery system which offers a scalable, natural, Generally Regarded As Safe (GRAS) approved solution for the oral delivery of metabolic peptide cargo to specific areas of the gut and into systemic circulation for the treatment of diabetes, obesity and other metabolic diseases.

Webull offers Poolbeg Pharma PLC stock information, including OTCPK: POLBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, POLBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading POLBF stock methods without spending real money on the virtual paper trading platform.